Diabetes complications and screening

On this page

Quick Overview

Diabetes complications are leading causes of preventable blindness, renal failure, and amputation in the UK. NICE NG28 mandates structured annual screening for microvascular (retinopathy, nephropathy, neuropathy) and macrovascular complications, with specific referral thresholds and foot risk stratification. Early detection through systematic surveillance reduces morbidity by 30-50%.

Core Facts & Concepts

Annual Screening Requirements (NICE NG28):

  • Retinopathy: Digital retinal photography annually from diagnosis (Type 2) or 5 years post-diagnosis (Type 1)
  • Nephropathy: Urinary ACR (albumin:creatinine ratio) + eGFR annually
  • Neuropathy: 10g monofilament testing + vibration sense annually
  • Foot examination: Visual inspection + risk stratification annually

Key Thresholds:

ParameterNormalMicroalbuminuriaMacroalbuminuria
ACR (mg/mmol)<33-30>30
ActionAnnual reviewConfirm x2, start ACEi/ARBNephrology referral if declining eGFR

CKD Staging in Diabetes:

  • Stage 1-2 (eGFR ≥60): Monitor annually if ACR <30
  • Stage 3a (eGFR 45-59): 6-monthly review
  • Stage 3b-5 (eGFR <45): Nephrology referral

Figure 1: Fundus photograph showing cotton wool spots, microaneurysms, and dot-blot haemorrhages

Diabetic Foot Risk Stratification:

  • Low risk (normal sensation, palpable pulses): Annual review
  • Moderate risk (neuropathy OR absent pulses): 3-6 monthly podiatry
  • High risk (neuropathy + absent pulses/deformity/previous ulcer): 1-3 monthly multidisciplinary team
  • Active ulcer/Charcot: Urgent specialist referral (≤24 hours)

Problem-Solving Approach

Retinopathy Referral Pathway:

  1. Background retinopathy (microaneurysms, hard exudates): Continue annual screening
  2. Pre-proliferative (cotton wool spots, venous beading): Ophthalmology referral within 4 weeks
  3. Proliferative (new vessels): Urgent referral within 1 week
  4. Maculopathy (exudates within 1 disc diameter of fovea): Referral within 6 weeks

Figure 2: Monofilament testing on plantar surface of foot showing pressure application technique

Nephropathy Management Steps:

  1. Confirm elevated ACR with 2 out of 3 samples over 3 months
  2. Optimize BP target: <130/80 mmHg (or <120/80 if ACR >70)
  3. Start ACEi or ARB regardless of BP if ACR >3
  4. Check U&Es 1-2 weeks after starting (expect creatinine rise <25%, K+ <5.5)
  5. Refer nephrology if eGFR <45, ACR >70, or declining eGFR >5 ml/min/year

🚩 Red Flags: Rapidly declining eGFR (>5 ml/min/year), non-visible haematuria with ACR >30, resistant hypertension - consider alternative renal pathology

Analysis Framework

Neuropathy Classification:

TypeFeaturesManagement
Peripheral sensoryGlove-stocking loss, reduced monofilamentFoot protection education, annual screening
Painful neuropathyBurning/shooting pain, worse at nightDuloxetine 60mg OD or pregabalin 150-300mg BD
AutonomicPostural hypotension, gastroparesis, erectile dysfunctionTreat symptoms, exclude other causes
MononeuropathyCN III palsy (pupil-sparing), carpal tunnelUsually self-limiting over 6-12 weeks

Foot Ulcer Assessment (SINBAD Score):

  • Site (forefoot/midfoot/hindfoot), Ischaemia (pedal pulses), Neuropathy, Bacterial infection, Area, Depth
  • Score ≥3: High amputation risk - urgent MDT referral

Visual Aid

Key Points Summary

Annual screening triad: Digital retinal photography, ACR + eGFR, 10g monofilament testing (NICE NG28)

ACR thresholds: 3-30 mg/mmol = microalbuminuria (start ACEi/ARB), >30 = macroalbuminuria (nephrology if eGFR <45)

Retinopathy referral: Pre-proliferative (4 weeks), proliferative (1 week), maculopathy (6 weeks)

BP target in nephropathy: <130/80 mmHg, or <120/80 if ACR >70 mg/mmol

Foot risk: High risk = neuropathy + absent pulses/deformity - 1-3 monthly MDT review

Active ulcer: Urgent referral ≤24 hours; assess ischaemia (ABPI <0.9 = vascular referral)

Painful neuropathy: First-line duloxetine 60mg OD or pregabalin 150-300mg BD

Practice Questions: Diabetes complications and screening

Test your understanding with these related questions

A 46-year-old man presents with recurrent episodes of severe flushing and diarrhea. CT shows liver metastases and a pancreatic mass. Chromogranin A is markedly elevated. What is the most likely primary tumor?

1 of 5

Flashcards: Diabetes complications and screening

1/10

Pregnant patients with T1DM should monitor their glucose _____

TAP TO REVEAL ANSWER

Pregnant patients with T1DM should monitor their glucose _____

multiple times during the day

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial